(Q39619588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

HuR expression is a marker of poor prognosis in renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Hanna Ronkainen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Pasi Hirvikoski

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ari Ristimäki

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

16 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

481-487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

The changing natural history of renal cell carcinoma

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Biomarkers in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

21 January 2018

HuR and mRNA stability

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Role of the RNA-binding protein HuR in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

The RNA-binding protein HuR regulates the expression of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Significance of COX-2 expression in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0141-6

Cyclooxygenase-2 expression: does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?

21 January 2018

1 reference

12 December 2020

Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma

1 reference

12 December 2020

The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma

1 reference

12 December 2020

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas

1 reference

12 December 2020

Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival

1 reference

12 December 2020

Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma.

1 reference

12 December 2020

Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR

1 reference

12 December 2020

Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression.

1 reference

12 December 2020

HuR: post-transcriptional paths to malignancy.

1 reference

12 December 2020

Posttranscriptional regulation of cancer traits by HuR

1 reference

12 December 2020

Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.

1 reference

12 December 2020

Parathyroid hormone-related protein is an independent prognostic factor for renal cell carcinoma

1 reference

12 December 2020

10.1007/S13277-010-0141-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161467%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference